High lactoferrin levels in disseminated intravascular coagulation and its possible negative role in coagulation

Thrombosis Research

Volumn 98, Issue 1, 2000, Pages 111-114

  Özsan, Hayri G ^a   Pehlıvan, Mustafa ^a   Demırkan, Fatih ^a   Ündar, Bülent ^a   Sayan, Murat ^a   Çehrelı, Cavit ^a  

^a DOKUZ EYLUL UNIVERSITY   (Turkey)

Author keywords

DIC; Febrile neutropenia; Lactoferrin; Leukomoid reaction

Indexed keywords

LACTOFERRIN;

ARTICLE; BLOOD CLOTTING; BLOOD LEVEL; CANCER; CLINICAL ARTICLE; CONTROLLED STUDY; DISSEMINATED INTRAVASCULAR CLOTTING; FEBRILE NEUTROPENIA; HUMAN; HUMAN CELL; INFECTION; LEUKEMOID REACTION; LEUKOCYTE ACTIVATION; PRIORITY JOURNAL;

BIOLOGICAL MARKERS; BLOOD COAGULATION; DISSEMINATED INTRAVASCULAR COAGULATION; HUMANS; LACTOFERRIN;

EID: 0033997410     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0049-3848(99)00214-5     Document Type: Article

References (21)

1. Anderson B.F., Baker H.M., Norris G.E., Rice D.W., Baker E.N. Structure of human lactoferrin. Crystallographic structure analysis and refinement at 2.8 a resolution J Mol Biol. 209:1989;711-734.
2. Iyer S., Lonnerdal B. Lactoferrin, lactoferrin receptor and iron metabolism. Eur J Clin Nutr. 47:1993;232-241.
3. Myauchi J., Watanabe Y., Enomoto Y., Takeuchi K. Lactoferrin deficient neutrophil polymorphonuclear leukocytes in leukaemias. A semiquantitative and ultrastractural ctochemical study J Clin Pathol. 36:1983;1397-1405.
4. Baynes R.D., Berwado W.R., Khan Q., Mansoor N. Relationship of plasma Lf content to neutrophil regeneration and bone marrow infusion. Scand J Haematol. 36:1986;79-84.
5. Nemet K., Solti V., Mod A., Paloczi K., Sereqedi G., Hollan Z. Plasma lactoferrin levels in leukomias. Clin Lab Haematol. 9:1987;137-145.
6. Weinberg E.D. Iron withholding a defence against infection and neoplasia. Physiol Rev. 64:1984;65-102.
7. Lee G.R. The anaemia of chronic disease. Semin Hematol. 20:1983;61-80.
8. Gentile P., Broxmeyer H.E. Suppression of mouse myelopoiesis by administration of human lactoferrin in vivo and comparative action of human transferrin. Blood. 61:1983;982-993.
9. Wu H., Lundblad R.L., Church F.C. Neutralization of heparin activation by neutrophil lactoferrin. Blood. 85:1995;421-428.
10. Bick R.L. Disseminated intravascular coagulation and related syndromes. Semin Thromb Hemost. 14:1988;299-338.
11. Spero J., Levis J., Hasiba Y. Disseminated intravascular coagulation, finding in 346 patients. Thromb Haemost. 42:1980;28-33.
12. Brown R.D., Yuen E., Rickard K.A., Vincent P.C., Young G., Kronenberg H. Plasma lactoferrin in patient with neutropenia. Blut. 52:1986;289-295.
13. Lash J.A., Coates T.D., Lefuze J., Baehner R.L., Boxer L.A. Plasma lactoferrin reflects granulocyte activation in vivo. Blood. 61:1983;885-888.
14. Bezweda W.R., Dajee D. Plasma lactoferrin content in neutropenic patients. Effect of treatment with recombinant granulocyte-macrophage colony-stimulating factor Mol Biother. 4:1992;103-106.
15. Adeyemi E.O., Hodgson H.J. Augmented release of human leukocyte lactoferrin (and elastase) during coagulation. J Clin Lab Immunol. 27:1988;1-4.
16. Adeyemi E.O., Campos L.B., Loizou S., Walport M.J., Hodgson H.J.F. Plasma lactoferrin and neutrophil elastase in rheumatoid arthritis and systemic lupus erythematosus. Brit J Rheum. 29:1990;15-20.
17. Pejler G. Lactoferrin regulates the activity of heparin proteoglycan-bound mast cell chymase. Characterisation of the binding of heparin to lactoferrin J Biochem. 320:1996;897-903.
18. Pratt C.W., Church F.C. General features of heparin binding serpins antithrombin, heparincofactor II, and protein-c inhibitor. Blood Coagul Fibrinolysis. 4:1993;479-490.
19. Van Deventher S.J.H., Büller H.R., Ten Cate J.W. Experimental endotoxemia in humans. Analysis of cytokin release and coagulation, fibrinolytic, and complement pathways Blood. 76:1990;2520-2526.
20. Taylor F.B. Role of tissue factor VIIa in the coagulant and inflammatory response to ld100 Escherichia coli in the baboon. Haemostasis. 26:1996;83-91.
21. Biemond B.J., Levi M., Ten Cate H. Complete inhibition of endotoxin-induced coagulation activation in chimpanzees with a monoclonal fab fragments against factor VII/VIIa. Thromb Haemost. 73:1995;223-230.